Docetaxel treatment for widely metastatic invasive vulvar extramammary Paget's disease with multifocal bone metastasis.

Gynecol Oncol Rep

Department of Obstetrics & Gynecology, Division of Gynecologic Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America.

Published: February 2023

•Invasive extramammary Paget's disease of the vulva is rare.•Distant metastasis has a very poor prognosis.•Given rarity of disease, no standardized treatment exists.•Single agent docetaxel is a viable treatment for metastatic invasive extramammary Paget's disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791582PMC
http://dx.doi.org/10.1016/j.gore.2022.101114DOI Listing

Publication Analysis

Top Keywords

extramammary paget's
12
paget's disease
12
treatment metastatic
8
metastatic invasive
8
docetaxel treatment
4
invasive vulvar
4
vulvar extramammary
4
disease
4
disease multifocal
4
multifocal bone
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!